American Society of Hirudotherapy

Genomics & Proteomics

Modern molecular approaches to medicinal leech biology

Last Updated: March 5, 2026Reviewed by: Andrei Dokukin, MD

Last updated: March 14, 2026

Classical biochemistry identified approximately 30–40 bioactive components in medicinal leech SGSry gland secretion over several decades of painstaking protein purification. Modern “omics” technologies have revolutionized this picture: genome sequencing, transcriptomics, and mass spectrometry proteomics have now identified over 200 proteins in leech SGS, revealing an unexpectedly complex pharmacological arsenal and opening new avenues for drug discovery.

Genome Assemblies

Kvist et al. (2020)

First comprehensive Hirudo medicinalis genome assembly. 19,929 scaffolds spanning 176.96 Mbp. Gene annotation identified 15 anticoagulation factors and 17 antihemostatic proteins — substantially more than the ~8 previously characterized by biochemistry. The assembly revealed gene duplication events in the hirudin and eglin gene families, suggesting functional diversification.

Genome Features

  • Assembly size: 176.96 Mbp (relatively compact for an invertebrate)
  • 19,929 scaffolds (fragmented — long-read sequencing needed)
  • 15 anticoagulation gene families identified
  • 17 antihemostatic gene families identified
  • Gene duplication in hirudin/eglin families
  • Repeat content: characteristic of lophotrochozoan genomes

Transcriptomics — Salivary Cell Gene Expression

Babenko et al. (2020)

RNA-seq analysis of salivary cells from three Hirudo species (H. medicinalis, H. orientalis, H. verbana). Co-authored by I.P. Baskova, linking classical biochemistry with modern genomics. The study revealed species-specific expression differences in salivary genes — a finding with practical implications, since different species may produce quantitatively different SGS profiles and therefore exhibit different clinical potencies.

Guan et al. (2024)

Investigated starvation-induced changes in the salivary proteome and transcriptome. Leeches upregulate specific anticoagulant and tissue-penetration genes during prolonged fasting, optimizing SGS composition for the next feeding event. This finding explains the traditional practice of using “hungry” leeches in clinical application — they produce a more potent and complex secretion.

Proteomics — Mass Spectrometry Era

Liu et al. (2019)

Comprehensive proteomic analysis using LC-MS/MS identified 434 full-length protein sequences in Hirudo saliva, of which 44 were confirmed bioactive through functional assays. This represents a 10-fold increase over the classical biochemistry inventory.

Novel ClassFunctionDrug Discovery Potential
M12/M13 ProteasesMetalloprotease tissue remodelingWound healing, anti-fibrotic
CRISP ProteinsCysteine-rich secretory proteins; immune modulationAnti-inflammatory leads
ApyraseADP hydrolysis; antiplateletAntiplatelet drug leads
Adenosine DeaminaseAdenosine metabolism; vasodilationCardiovascular modulation
CystatinsCysteine protease inhibitionAnti-inflammatory, antiparasitic
FicolinsLectin complement pathway activationInnate immunity modulation

Structural Biology Breakthroughs

Tandem-Hirudin (Hohmann et al., 2022)

Discovery of the first oligomeric hirudin — a hirudin variant that forms tandem multimers. Unlike classical hirudin, tandem-hirudin shows no direct thrombin inhibitory activity, suggesting a novel, as-yet-uncharacterized biological function. This finding challenges the assumption that all hirudin family members are anticoagulants.

Destabilase Crystal Structure (Zavalova et al., 2023)

Crystal structure of destabilase resolved at 1.1 Angstrom resolution — the highest-resolution structure of any leech salivary protein. The structure revealed a revised catalytic mechanism for isopeptidase activity, clarifying how destabilase cleaves cross-linked fibrin through a mechanism distinct from classical lysozyme catalysis.

From ~30 to 200+ Identified Proteins

Paradigm Shift

Classical biochemistry (1950s–2000s) identified approximately 30–40 bioactive components through painstaking individual protein purification. Modern omics approaches have expanded this to over 200 identified proteins. The majority remain functionally uncharacterized — each representing a potential drug lead or biological insight into the most pharmacologically complex animal secretion known.

Future Directions

Single-Cell Transcriptomics

scRNA-seq of individual salivary gland cells will reveal which cell types produce which SGS components, enabling targeted manipulation of specific bioactive pathways.

CRISPR Functional Studies

Gene knockout/knockdown in leech SGSry cells will establish definitive gene–function relationships for the hundreds of uncharacterized salivary proteins identified by proteomics.

Synthetic Biology

Recombinant production of individual SGS components or designed multi-component cocktails could enable standardized, leech-free delivery of specific therapeutic combinations.

Related Resources

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.